Robert M. Levy
University of Florida
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert M. Levy.
Neuromodulation | 2007
Timothy R. Deer; Elliot S. Krames; Samuel J. Hassenbusch; Allen W. Burton; David Caraway; Stuart DuPen; James C. Eisenach; Michael A. Erdek; Eric Grigsby; Phillip Kim; Robert M. Levy; Gladstone McDowell; Nagy Mekhail; Sunil Panchal; Joshua Prager; Richard Rauck; Michael Saulino; Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; K. Dean Willis; William W. Witt; Kenneth A. Follett; Marc A. Huntoon; Leong Liem; James P. Rathmell; Mark S. Wallace; Eric Buchser; Michael Cousins
Background. Expert panels of physicians and nonphysicians in the field of intrathecal therapies convened in 2000 and 2003 to make recommendations for the rational use of intrathecal analgesics based on the preclinical and clinical literature known up to those times. An expert panel of physicians convened in 2007 to update previous recommendations and to form guidelines for the rational use of intrathecal opioid and nonopioid agents.
Neuromodulation | 2014
Timothy R. Deer; Nagy Mekhail; David A. Provenzano; Jason E. Pope; Elliot S. Krames; Michael Leong; Robert M. Levy; David Abejón; Eric Buchser; Allen W. Burton; Asokumar Buvanendran; Kenneth D. Candido; David Caraway; Michael Cousins; Mike J. L. DeJongste; Sudhir Diwan; Sam Eldabe; Kliment Gatzinsky; Robert D. Foreman; Salim M. Hayek; Philip Kim; Thomas M. Kinfe; David Kloth; Krishna Kumar; Syed Rizvi; Shivanand P. Lad; Liong Liem; Bengt Linderoth; S. Mackey; Gladstone McDowell
The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia, and refractory angina and recommended appropriate clinical applications.
Neuromodulation | 2013
Liong Liem; Marc Russo; Frank Huygen; Jean Pierre Van Buyten; Iris Smet; Paul Verrills; Michael Cousins; Charles Brooker; Robert M. Levy; Timothy R. Deer; Jeffery M. Kramer
This multicenter prospective trial was conducted to evaluate the clinical performance of a new neurostimulation system designed to treat chronic pain through the electrical neuromodulation of the dorsal root ganglia (DRG) neurophysiologically associated with painful regions of the limbs and/or trunk.
Neuromodulation | 2012
Timothy R. Deer; Robert M. Levy; Joshua Prager; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; Allen W. Burton; Eric Buchser; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Phillip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; B. Todd Sitzman; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail
Introduction: Trialing for intrathecal pump placement is an essential part of the decision‐making process in placing a permanent device. In both the United States and the international community, the proper method for trialing is ill defined.
Neuromodulation | 2011
Robert M. Levy; Jaimie M. Henderson; Konstantin V. Slavin; Brian Simpson; Giancarlo Barolat; Jane Shipley; Richard B. North
Introduction: While reference is frequently made to the risk of spinal cord or nerve root injury with the surgical implantation of paddle type spinal cord stimulation (SCS) electrodes, data are lacking on the frequency, causes, and prevention of these complications.
Neuromodulation | 2014
Joshua Prager; Timothy R. Deer; Robert M. Levy; Brian M. Bruel; Eric Buchser; David Caraway; Michael Cousins; Marilyn S. Jacobs; Gail McGlothlen; Richard Rauck; Peter S. Staats; Lisa Stearns
The objective of this study was to identify best practices and provide guidance to clinicians to ensure safety and optimize intrathecal drug delivery for chronic intractable pain.
Neuromodulation | 2012
Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh
Introduction: Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been associated with noninfectious inflammatory masses at the tip of the intrathecal catheter, which can result in neurologic complications.
Archive | 1997
Richard B. North; Robert M. Levy
1 Pain Physiology and Clinical Presentation.- 1. Physiology of Pain.- 2. Psychological and Psychiatric Aspects of Pain.- 3. Rehabilitation and Treatment Outcome.- 4A. Low Back Pain.- 4B. Low Back Pain.- 4C. Ischemic Pain.- 5. Chronic Nociceptive Pain Syndromes: Cancer Pain.- 6. Peripheral Nerve Injury and Sympathetically Maintained Pain: Mechanisms and Surgical Approach.- 7. Facial and Cranial Pain.- 8. Chronic Pain Syndromes of the Central Nervous System.- A. Phantom and Stump Pain.- B. Cervical Brachial Plexus Avulsion.- C. Central Pain of Spinal Cord Origin.- 9. Pharmacotherapy of Chronic Pain.- 2 Neurosurgical Procedures: Anatomic and Ablative.- 10. Neurosurgical Procedures of the Peripheral Nerves.- 11. Neurosurgical Procedures of the Sympathetic Nervous System.- 12. DREZ Lesions for Treatment of Pain.- 13. Cordotomy and Myelotomy.- 14. Trigeminal Nerve and Ganglion Procedures.- 15. Intracranial Ablative Procedures.- 3 Neurosurgical Procedures: Augmentative.- 16. Peripheral Nerve Stimulation.- 17. Spinal Cord Stimulation.- 18. Brain Stimulation.- 19. Implanted Drug Delivery Systems for Control of Chronic Pain.- 4 Algorithms and Guidelines.- 20. Facial Pain.- 21. Cancer Pain.- 22. Algorithms for Treatment of Neuropathic Pain Syndromes.- 23. Chronic Low Back Pain and Failed Back Surgery Syndrome.
Neuromodulation | 2014
Timothy R. Deer; Nagy Mekhail; David A. Provenzano; Jason E. Pope; Elliot S. Krames; Simon Thomson; Lou Raso; Allen W. Burton; Jose DeAndres; Eric Buchser; Asokumar Buvanendran; Liong Liem; Krishna Kumar; Syed Rizvi; Claudio Feler; David Abejón; Jack Anderson; Sam Eldabe; Philip Kim; Michael Leong; Salim M. Hayek; Gladstone McDowell; Lawrence Poree; Elizabeth S. Brooks; Tory McJunkin; Paul Lynch; Robert D. Foreman; David Caraway; Ken Alo; Samer Narouze
The International Neuromodulation Society (INS) has determined that there is a need for guidance regarding safety and risk reduction for implantable neurostimulation devices. The INS convened an international committee of experts in the field to explore the evidence and clinical experience regarding safety, risks, and steps to risk reduction to improve outcomes.